Pivot Bio has raised USD $ 750,000 in Seed, USD $16 million in Series A, USD $71.3 million in Series B, USD $100 million in Series C, and USD $430 million in Series D, totaling approximately USD $618 million in funding. The latest $430 M round in July 2021 valued the company at about USD $2 billion. Founded in 2010, Pivot Bio provides microbe-based nitrogen-fixing solutions for crops. These funds will be used to scale their biological nitrogen fixation products across major agricultural markets, expand manufacturing, and accelerate the global rollout of sustainable crop nutrition technologies.